Jaraa'idJaraa'id
Notification Show More
Latest News
Air India boss hails biggest turnround effort in airline’s history
Business
Antonio Conte leaves Tottenham by mutual consent, Cristian Stellini to take charge of team for rest of season
Sports
European ammunition maker says plant expansion hit by energy-guzzling TikTok site
Business
Robin van Persie tipping ‘champion team’ Arsenal to end 19-year wait and win Premier League
Sports
Netanyahu sacks defence minister over refusal to back judicial reform
Business
Aa
  • Home
  • Local News
  • Africa
  • United States
  • Europe
  • Asia
  • Sports
  • Videos
  • Live Score
  • More
    • Business
    • Market Data
      • Stocks
      • Commodities
      • Cryptocurrency
      • Forex
    • Weather
Reading: Texas judge holds key hearing in abortion-pill lawsuit
Share
Aa
Jaraa'idJaraa'id
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Business
  • Sports
  • Videos
Search
  • Home
  • Local News
  • Videos
  • World
    • Africa
    • United States
    • Europe
    • Asia
  • Market Data
    • Stocks
    • Commodities
    • Cryptocurrency
    • Forex
  • More
    • Sports
    • Business
    • Weather
    • Live Score
Have an existing account? Sign In
Follow US
Jaraa'id > United States > Texas judge holds key hearing in abortion-pill lawsuit
United States

Texas judge holds key hearing in abortion-pill lawsuit

News Room
Last updated: 2023/03/15 at 8:13 AM
News Room Published March 15, 2023
Share
SHARE

AMARILLO, Tex. — A federal judge on Wednesday will consider an unprecedented effort to undo long-standing government approval of the abortion medication used in most pregnancy terminations nationwide.

U.S. District Judge Matthew Kacsmaryk is expected to question lawyers in the case that seeks to restrict access to mifepristone, the medication first approved by the Food and Drug Administration more than 20 years ago.

The high-stakes hearing, for which the judge has allotted up to four hours, will be the first time the judge engages directly with lawyers for the Justice Department, representing the FDA; the company that manufactures and distributes the drug; and the antiabortion group challenging the medication. Kacsmaryk could rule at any time following the hearing, potentially disrupting access to the widely used drug, including in states where abortion is legal.

If Kacsmaryk sides with the plaintiffs, it would be the first time a court has ordered the government to withdraw or suspend approval of a medication despite opposition from the FDA and the drug’s manufacturer.

Medication-induced abortion has become increasingly contentious since the Supreme Court’s conservative majority overturned Roe v. Wade last June, eliminating the constitutional right to terminate a pregnancy.

The lawsuit was brought by the legal group Alliance Defending Freedom on behalf of antiabortion medical organizations and four doctors who say they have treated patients with mifepristone. The complaint accuses the FDA of approving an “unsafe drug regimen” without sufficient study and objects to recent steps that make it easier to obtain the medication.

Public health professionals and legal experts have denounced the lawsuit as unsupported by scientific evidence. The FDA has repeatedly found the two-step medication abortion protocol to be a safe and effective alternative to surgical abortions.

Justice Department lawyers object to the court potentially second-guessing the FDA’s technical expertise and have called the request for an injunction “extraordinary and unprecedented.” The lawsuit, the government said in court filings, is based on false claims that the drug inflicts severe complications and “fails to acknowledge that the alternatives to mifepristone — surgical abortion or continued pregnancy — also have rates of complications, with childbirth’s being substantially higher than mifepristone’s.”

How the Texas lawsuit could change access to medication-induced abortion

In a two-step medication abortion, a patient first takes one mifepristone pill, which terminates the pregnancy. Approximately 24 hours later, they typically take a four-pill dose of misoprostol, a drug introduced in 1973 to treat stomach ulcers, to soften the cervix and prompt contractions that expel the embryo or fetus. While misoprostol is widely used on its own to perform abortions around the world, studies show it is less effective than the two-step regimen, and usually causes more cramping and bleeding.

Without access to mifepristone, many providers say, they would continue to offer medication abortions using only misoprostol. Some would perform only surgical abortions. Providers said either scenario would result in massive upheaval as they try to enact new procedures, which some clinic owners fear may present legal hurdles. A few have been stockpiling mifepristone in anticipation of the ruling, hoping they would still be permitted to distribute the pills they already have regardless of Kacsmaryk’s decision.

Kacsmaryk, a nominee of President Donald Trump, has attracted criticism from abortion rights advocates because of his long-held antiabortion views. The scheduling of the hearing on Wednesday was also a source of controversy after the judge intentionally delayed public notice and asked lawyers for the parties to keep quiet about the planned hearing — actions he said he was taking to try to minimize disruptions, security threats and protests. Kacsmaryk said he might wait until late Tuesday to announce the hearing, which typically would have been posted on the court docket soon after the call.

After The Washington Post reported on the judge’s directive to lawyers, a coalition of media organizations criticized the decision, and the judge formally posted notice of the hearing on Monday.

This is a developing story. It will be updated.

Read the full article here

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room March 15, 2023
Share this Article
Facebook Twitter Email Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular News
Business

Air India boss hails biggest turnround effort in airline’s history

News Room News Room March 26, 2023
Antonio Conte leaves Tottenham by mutual consent, Cristian Stellini to take charge of team for rest of season
European ammunition maker says plant expansion hit by energy-guzzling TikTok site
Robin van Persie tipping ‘champion team’ Arsenal to end 19-year wait and win Premier League
Netanyahu sacks defence minister over refusal to back judicial reform
Miami Open 2023: Bianca Andreescu marches on with win over Sofia Kenin, Belinda Bencic becomes latest big name to fall
US Vice President Kamala Harris in Africa to boost ties
The News Puzzle: test your knowledge of this month’s events
- Advertisement -
Ad imageAd image

You Might also Like

United States

Actor Jonathan Majors arrested in New York on assault charges

March 26, 2023
United States

US lawmaker says FBI briefed him on Trump’s rhetoric over New York probe

March 26, 2023
United States

Rep. Ro Khanna endorses Rep. Barbara Lee in Senate race in California

March 26, 2023
United States

US House speaker says lawmakers to move forward with TikTok bill

March 26, 2023
  • Somalia
  • Africa
  • United States
  • Europe
  • Asia
  • Cryptocurrency
  • Forex
  • Stock Market

About US

Jaraa'id is your one-stop website for the latest global and local news and updates, follow us now to get the news that matters to you.
Quick Link
  • Privacy Policy
  • Terms of use
  • Press ReleaseSubmit
  • Advertise
  • Contact
Top Sections
  • Business
  • Sports
  • Videos
  • Market DataLive
  • Weather

Subscribe US

Subscribe to our newsletter to get our Latest articles instantly!

I have read and agree to the terms & conditions

2023 © Jaraa'id. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?